Sentinel lymph node biopsy (SLNB) guides adjuvant therapy in breast cancer. There is controversy regarding its use in elderly women with low-risk breast cancer. This study aimed to determine whether a positive SLNB in this group affected the decision to offer adjuvant therapy compared with younger patients. This retrospective review included 492 patients, 89 of whom had a positive SLNB. Elderly, node-positive women were significantly less likely to receive chemotherapy than their younger counterparts (P < .0001), suggesting the use of SLNB in the elderly could be rationalized. K E Y W O R D Sadjuvant therapy, breast cancer, chemotherapy, elderly, node positivity, sentinel lymph node biopsy

No abstract

This abstract was withdrawn by the authors. Citation Format: Blackhall VI, Bugelli M, Abbott NA, Mullen R. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-03-33.